Dexcom is funding a large clinical test to be presented at the national diabetes conference on June 6. It might be a good time to watch it for an investment opportunity. It involves expanding its uses type 1 diabetes which involves many more users. it is profiled on page a 8 of today’s san diego union tribune.
1 Like